首页> 外国专利> use of a benzodiazepine or a pharmaceutically acceptable salt thereof, method for treating or preventing an hcv infection in a patient, benzodiazepine derivative or a pharmaceutically acceptable salt thereof, and pharmaceutical composition

use of a benzodiazepine or a pharmaceutically acceptable salt thereof, method for treating or preventing an hcv infection in a patient, benzodiazepine derivative or a pharmaceutically acceptable salt thereof, and pharmaceutical composition

机译:苯二氮卓或其药学上可接受的盐的用途,用于治疗或预防患者的hcv感染的方法,苯二氮卓衍生物或其药学上可接受的盐以及药物组合物

摘要

USE OF A BENZODIAZEPIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD TO TREAT OR PREVENT HCV INFECTION IN A PATIENT, BENZODIAZEPIN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE COMPOSITION. The use of a benzodiazepine of formula (1), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in the treatment or prevention of a hepatitis C infection, wherein: R represents C 1-6 alkyl aryl or heteroaryl; R 2 represents hydrogen or C 1-6 alkyl; each R is the same or different and represents halogen, hydroxy, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 thioalkyl, C 1-6 haloalkyl, C 1-1 haloalkoxy -6-, amino, mono (C1-6 alkyl) amino, di (C1-6 alkyl) amino, nitro, cyano, -CO2-2 R ', -CONR'R ", -NH -CO-R ', S (O) R', -S (O) -2-R ', -NH-S (O) -2-R', -S (O) NR'R "or. -S (O) ~ 2-NR'R "where each R 'and R" is the same or different and represents hydrogen or C 1-6 alkyl; - n is from 0 to 3; - represents hydrogen or C 1-6 alkyl; - R5-5 represents C1-6 alkyl, aryl, heteroaryl, carbocyclyl, heterocyclyl, aryl (C1-6 alkyl) -, heteroaryl (C1-6 alkyl) -, carbocyclyl ( C 1-6 ~ - heterocyclyl (C 1-6 alkyl), aryl (C 1-6 hydroxyalkyl), heteroaryl (C 1-6 hydroxyalkyl), carbocyclyl (C 1-6 hydroxyalkyl) -1-6-) -, heterocyclyl- (C 1-6 hydroxyalkyl) -, aryl-C (O) -C (O) -, heteroaryl-C (O) -C (O) - carbocyclyl-C (O) -C (O) -, heterocyclyl-C (O) -C (O) - or -XR; X represents -CO-, -S (O) - or -S (O) -2 -; and R 6 'represents C 1-6 alkyl, hydroxy, C 1-6 alkoxy, C 1-6 thioalkyl, aryl, heteroaryl, carbocyclyl, heterocyclyl, aryl (C 1-6 alkyl) ) -, heteroaryl - (C 1-6 alkyl) -, carbocyclyl (C 1-6 alkyl) -, heterocyclyl (C 1-6 alkyl) -, aryl (C 1-6 alkyl) ~) - O-, heteroaryl (C 1-6 alkyl) -O-, carbocyclyl (C 1-6 alkyl) -O-, heterocyclyl (C 1-6 alkyl) -O- or -NTR'R "where each R 'and R" is the same or different and represents hydrogen, C 1-6 alkyl, carbocyclyl, heterocyclyl, aryl, het eroaryl, aryl- (C 1-6 ~ heteroaryl - (C 1-6 earbocyclyl - (C 1-6 alkyl)) or heterocyclyl (C 1-6 alkyl)
机译:使用苯二氮卓平或药学上可接受的盐,在患者,苯并二氮杂卓衍生物或药学上可接受的组合物中治疗或预防HCV感染的方法。式(1)的苯并二氮杂或其药学上可接受的盐在制备用于治疗或预防丙型肝炎感染的药物中的用途,其中:R代表C 1-6烷基芳基或杂芳基; R 2代表氢或C 1-6烷基;每个R是相同或不同的并且代表卤素,羟基,C 1-6烷基,C 1-6烷氧基,C 1-6硫代烷基,C 1-6卤代烷基,C 1-1卤代烷氧基-6,氨基,单( C 1-6烷基)氨基,二(C 1-6烷基)氨基,硝基,氰基,-CO2-2 R',-CONR'R“,-NH -CO-R',S(O)R',-S (O)-2-R',-NH-S(O)-2-R',-S(O)NR'R”或。 -S(O)〜2-NR′R“其中每个R′和R”相同或不同,代表氢或C 1-6烷基; -n为0到3; -代表氢或C 1-6烷基; -R5-5代表C1-6烷基,芳基,杂芳基,碳环基,杂环基,芳基(C1-6烷基)-,杂芳基(C1-6烷基)-,碳环基(C 1-6〜-杂环基(C1-6烷基),芳基(C 1-6羟烷基),杂芳基(C 1-6羟烷基),碳环基(C 1-6羟烷基)-1-6-)-,杂环基-(C 1-6羟烷基)-,芳基- C(O)-C(O)-,杂芳基-C(O)-C(O)-碳环基-C(O)-C(O)-,杂环基-C(O)-C(O)-或- XR; X代表-CO-,-S(O)-或-S(O)-2-;和R 6'代表C 1-6烷基,羟基,C 1-6烷氧基,C 1-6硫代烷基,芳基,杂芳基,碳环基,杂环基,芳基(C 1-6烷基))-,杂芳基-(C 1- 6烷基)-,碳环基(C 1-6烷基)-,杂环基(C 1-6烷基)-,芳基(C 1-6烷基)〜)-O-,杂芳基(C 1-6烷基)-O- ,碳环基(C 1-6烷基)-O-,杂环基(C 1-6烷基)-O-或-NTR'R“其中每个R'和R”相同或不同,表示氢,C 1-6烷基,碳环基,杂环基,芳基,杂杂芳基,芳基-(C 1-6〜杂芳基-(C 1-6耳环基-(C 1-6烷基))或杂环基(C 1-6烷基)

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号